Feedback / Questions
golcadomide (CC-99282) - BMS
Calquence (acalabrutinib) - AstraZeneca
cemacabtagene ansegedleucel (ALLO-501A) - Allogene Therap
https://www.prnewswire.com/news-releases/foresight-diagnostics-announces-multiple-presentations-in-lymphoma-featuring-phased-seq-ultrasensitive-mrd-analysis-at-the-upcoming-ash-annual-meeting-302631204.html
Dec 3, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next